Malvern Panalytical will show OmniTrust, a suite of data integrity solutions, at a live online event on 13 October.
The product provides a common approach for compliance with regulatory requirements for data lifecycle management and protects the integrity of analytical workflows.
Product Group Manager Deborah Huck-Jones said: “In developing OmniTrust, we've really studied our customers’ workflows to understand their challenges and identify the bottlenecks in their control and review processes.
“Decisions that affect data integrity begin before a measurement has even been made, so we started at the point when a customer is looking to purchase an instrument and worked through how they then use and validate their system. The result is a combination of services and software that gives them greater transparency in their records and absolute confidence in the integrity of their data.”
OmniTrust is underpinned by Amplify Analytics, which aims to accelerate and de-risk drug development. The company says this combination provides the analytics know-how, instrumentation and validation support that enables customers to speed successful development whilst easing the regulatory burden associated with data integrity and compliance.
“In today’s fast-paced pharmaceutical development environment, our customers are balancing the race to drive innovation and improve productivity with the requirement to ensure compliance within complex regulatory frameworks,” said Paul Kippax, Sector Director.
“At Malvern Panalytical, we understand that accessing our cutting-edge analytical techniques can help speed lifesaving pharmaceutical products to market. Amplify Analytics, supported by OmniTrust solutions, ensures you apply the right methods, delivering the right data at the right time to inform critical development and manufacturing decisions.”
The live launch event will include a panel discussion between Paul Kippax and Deborah Huck-Jones, both of Malvern Panalytical, together with Caroline German, Technical Director, and Gregg Imrie, Computer Systems Validation Expert, both of Concept Life Sciences. The discussion will be immediately followed by a dedicated Q&A session.